glucagon has been researched along with nephrin in 2 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (nephrin) | Trials (nephrin) | Recent Studies (post-2010) (nephrin) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 1,130 | 9 | 621 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aaltonen, P; Ahola, H; Holthöfer, H; Jaakkola, I; Knip, M; Luimula, P; Otonkoski, T; Palgi, J; Palmén, T; Wang, S | 1 |
| Chodavarapu, H; Elased, KM; Grobe, N; Madhu, M; Salem, ES; Somineni, HK | 1 |
2 other study(ies) available for glucagon and nephrin
| Article | Year |
|---|---|
Nephrin is expressed in the pancreatic beta cells.
Topics: Cadaver; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Fluorescent Dyes; Gene Expression; Glucagon; Humans; Immunoblotting; Islets of Langerhans; Keratins; Kidney; Kidney Cortex; Membrane Proteins; Molecular Weight; Pancreas; Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Somatostatin | 2001 |
Rosiglitazone treatment of type 2 diabetic db/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion.
Topics: ADAM Proteins; ADAM17 Protein; Albuminuria; Angiotensin-Converting Enzyme 2; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucagon; Glucose Tolerance Test; Glycosuria; Hyperglycemia; Hypoglycemic Agents; Kidney Diseases; Male; Membrane Proteins; Mice; Peptidyl-Dipeptidase A; Rosiglitazone; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-3; Triglycerides | 2013 |